Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dustin Wade Wooten, Ph.D.

Concepts

This page shows the publications Dustin Wooten has written about Piperazines.
Connection Strength

0.767
  1. Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. J Cereb Blood Flow Metab. 2012 Aug; 32(8):1546-58.
    View in: PubMed
    Score: 0.220
  2. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nucl Med Biol. 2011 Oct; 38(7):925-32.
    View in: PubMed
    Score: 0.209
  3. In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse. 2011 Jul; 65(7):592-600.
    View in: PubMed
    Score: 0.201
  4. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans. J Comp Neurol. 2016 May 01; 524(7):1457-71.
    View in: PubMed
    Score: 0.071
  5. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. J Nucl Med. 2014 Dec; 55(12):1973-9.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.